North Kansas City, MONCT04781192Now EnrollingIRB Ready

Biliary Tract Cancer Clinical Trial in North Kansas City, MO

Access cutting-edge biliary tract cancer treatment through this clinical trial at a research site in North Kansas City. Study-provided care at no cost to qualified participants.

Sponsored by University of Kansas Medical Center

Quick Self-Assessment

See if you qualify for this North Kansas City location

Preparing your pre-screening questions...

Expert Care in North Kansas City

Access biliary tract cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related biliary tract cancer treatment provided free

Apply for This North Kansas City Location

Check if you qualify for this biliary tract cancer clinical trial in North Kansas City, MO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to North Kansas City

    Convenient for MO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit North Kansas City site if eligible
  4. 4Begin participation

About This Biliary Tract Cancer Study in North Kansas City

The purpose of this study is to measure how effective combining Durvalumab and Regorafenib will be for participants with advance stage biliary track carcinoma who have received one line of prior treatment

Sponsor: University of Kansas Medical Center

Who Can Participate

Inclusion Criteria

Ability of patient OR Legally Authorized Representative (LAR) to understand this study, and participant or LAR willingness to sign a written informed consent
Can swallow tablets and self-administer medication
Progressed on at least one line of therapy (no restrictions on type of previous treatment)
Eastern Cooperative Oncology Group (ECOG) Performance Status = 0 - 1
Measurable disease with at least 1 lesion that qualifies as a RECIST 1.1 Target Lesion (TL) at baseline. Previously irradiated lesion cannot be considered as Target Lesion (TL) except in cases of documented progression of the lesion since the completion of radiation therapy
Histologically confirmed unresectable or metastatic intrahepatic/extrahepatic cholangiocarcinoma or gallbladder cancer with radiographic progression, who have progressed on one line of therapy / failed adjuvant therapy
Life expectancy of at least 3 months
Recovery to baseline or \< Grade 2 CTCAE v5.0 from toxicities r

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in North Kansas City?

Yes, this clinical trial (NCT04781192) has an active research site in North Kansas City, MO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Biliary Tract Cancer Treatment Options in North Kansas City, MO

If you're searching for biliary tract cancer treatment options in North Kansas City, MO, this clinical trial (NCT04781192) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our North Kansas City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced biliary tract cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all biliary tract cancer clinical trials near you to find additional studies recruiting in your area.

More Gallbladder Cancer Trials in North Kansas City, MO

See all gallbladder cancer clinical trials recruiting in North Kansas City — not just this study.

Browse Gallbladder Cancer Trials in North Kansas City

Ready to Join in North Kansas City?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · North Kansas City, MO